The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Regulation of pulmonary fibrosis by chemokine receptor CXCR3
Open accessAbstract
CXC chemokine receptor 3 (CXCR3) is the receptor for the IFN-γ-inducible C-X-C chemokines MIG/CXCL9, IP-10/ CXCL10, and I-TAC/CXCL11.CXCR3 is expressed on activated immune cells and proliferating endothelial cells.The role of CXCR3 in fibroproliferation has not been investigated.We examined the role of CXCR3 in pulmonary injury and repair in vivo.CXCR3-deficient mice demonstrated increased mortality with progressive interstitial fibrosis relative to WT mice.Increased fibrosis occurred without increased inflammatory cell recruitment.CXCR3 deficiency resulted in both a reduced early burst of IFN-γ production and decreased expression of CXCL10 after lung injury.We identified a relative deficiency in lung NK cells in the unchallenged CXCR3-deficient lung and demonstrated production of IFN-γ by WT lung NK cells in vivo following lung injury.The fibrotic phenotype in the CXCR3-deficient mice was significantly reversed following administration of exogenous IFN-γ or restoration of endogenous IFN-γ production by adoptive transfer of WT lymph node and spleen cells.Finally, pretreatment of WT mice with IFN-γ-neutralizing Ab's enhanced fibrosis following lung injury.These data demonstrate a nonredundant role for CXCR3 in limiting tissue fibroproliferation and suggest that this effect may be mediated, in part, by the innate production of IFN-γ following lung injury.Nonstandard abbreviations used: bronchoalveolar lavage (BAL); CXC chemokine receptor 3 (CXCR3); idiopathic interstitial pneumonia (IIP); idiopathic pulmonary fibrosis (IPF).Conflict of interest: P. Noble is a paid consultant for Intermune Pharmaceuticals, who is developing IFN-�1b for therapeutic use in patients with pulmonary fibrosis.R. Homer has received honoraria from Intermune Pharmaceuticals for lecturing at CME-sponsored programs on the pathology of idiopathic pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Self-citationLoetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Self-citationCole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870
Balashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 849
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Ulloa, L., Doody, J., & Massagué, J. (1999) · Nature · doi:10.1038/17826 · Cited by 812
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
Luster, A. D., & Ravetch, J. V. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1084 · Cited by 666
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Self-citationRequirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T., Ling, M., Gerard, N. P., & Gerard, C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1515 · Cited by 617
Self-citationZiesche, R., Hofbauer, E., Wittmann, K., Petkov, V., & Block, L.-H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411703 · Cited by 586
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed Central · Cited by 479
Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K., Libby, P., & Luster, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6993 · Cited by 464
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.
Luster, A. D., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1057 · Cited by 407
CXCR3 and CCR5 Ligands in Rheumatoid Arthritis Synovium
Patel, D. D., Zachariah, J. P., & Whichard, L. P. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4957 · Cited by 330
Gurujeyalakshmi, G., & Giri, S. N. (1995) · Experimental Lung Research · doi:10.3109/01902149509050842 · Cited by 303
β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis
Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Holländer, G. A., & Piali, L. (2002) · Nature Medicine · doi:10.1038/nm1202-792 · Cited by 301
Self-citationSchreiber, R. D., Hicks, L. J., Celada, A., Buchmeier, N. A., & Gray, P. W. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.3.1609 · Cited by 284
Keane, M. P., Belperio, J. A., Arenberg, D. A., Burdick, M. D., Xu, Z., Xue, Y., & Strieter, R. M. (1999) · PubMed · Cited by 232
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y. Y., Li, K., Ross, D. J., & Strieter, R. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1037 · Cited by 230
Keane, M. P., Belperio, J. A., Arenberg, D. A., Burdick, M. D., Xu, Z. J., Xue, Y. Y., & Strieter, R. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5686 · Cited by 212
Involvement of the IP-10 Chemokine in Sarcoid Granulomatous Reactions
Agostini, C., Cassatella, M., Zambello, R., Trentin, L., Gasperini, S., Perin, A., Piazza, F., Siviero, M., Facco, M., Dziejman, M., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6413 · Cited by 181
Chemokines and Their Receptors in Lymphocyte Traffic and HIV Infection
Loetscher, P., Moser, B., & Baggiolini, M. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60910-4 · Cited by 176
Xie, J. H., Nomura, N., Lu, M., Chen, S.-L., Koch, G. E., Weng, Y., Rosa, R., Di Salvo, J., Mudgett, J., Peterson, L. B., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102573 · Cited by 167
Krug, A., Uppaluri, R., Facchetti, F., Dorner, B. G., Sheehan, K. C. F., Schreiber, R. D., Cella, M., & Colonna, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6079 · Cited by 160
IL-12 attenuates bleomycin-induced pulmonary fibrosis
Keane, M. P., Belperio, J. A., Burdick, M. D., & Strieter, R. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l92 · Cited by 146
Chemokines: Not just leukocyte chemoattractants in the promotion of cancer
Strieter, R. M. (2001) · Nature Immunology · doi:10.1038/86286 · Cited by 140
Chen, E. S., Greenlee, B. M., Wills-Karp, M. A., & Möller, D. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4064 · Cited by 125
Gao, P. H., Zhou, X., Yashiro–Ohtani, Y., Yang, Y.-F., Sugimoto, N., Ono, S., Nakanishi, T., Obika, S., Imanishi, T., Egawa, T., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602269 · Cited by 115
Langenkamp, A., Nagata, K., Murphy, K. E., Wu, L., Lanzavecchia, A., & Sallusto, F. (2003) · European Journal of Immunology · doi:10.1002/immu.200310023 · Cited by 114
Ferrero, E., Biswas, P., Vettoretto, K., Ferrarini, M., Uguccioni, M., Piali, L., Leone, B. E., Moser, B., Rugarli, C., & Pardi, R. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01600.x · Cited by 112
Type 1/Type 2 Cytokine Paradigm and the Progression of Pulmonary Fibrosis
Lukacs, N. W., Hogaboam, C. M., Chensue, S. W., Blease, K., & Kunkel, S. L. (2001) · CHEST Journal · doi:10.1378/chest.120.1_suppl.s5 · Cited by 110
Narumi, S., Kaburaki, T., Yoneyama, H., IWAMURA, H., Kobayashi, Y., & Matsushima, K. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200206)32:6<1784::aid-immu1784>3.0.co;2-r · Cited by 95
Fischer, F. R., Santambrogio, L., Luo, Y., Berman, M. A., Hancock, W. W., & Dorf, M. E. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00351-9 · Cited by 95
Effect of Murine Gamma Interferon on the Cellular Responses to Bleomycin in Mice
Hyde, D. M., Henderson, T. S., Giri, S. N., Tyler, N. K., & Stovall, M. Y. (1988) · Experimental Lung Research · doi:10.3109/01902148809087837 · Cited by 91
Kabashima, H., Yoneda, M., Nagata, K., Hirofuji, T., & Maeda, K. (2002) · Cytokine · doi:10.1006/cyto.2002.1985 · Cited by 91
CXCR3 expression in human central nervous system diseases
Goldberg, S. H., van der Meer, P., Hesselgesser, J., Jaffer, S., Kolson, D. L., Albright, A. V., González‐Scarano, F., & Lavi, E. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00312.x · Cited by 89
Arenberg, D. A., Zlotnick, A., Strom, S. R. B., Burdick, M. D., & Strieter, R. M. (2001) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000147 · Cited by 62
Interferon-γ Production by Specific Lung Lymphocyte Phenotypes in Silicosis in Mice
Davis, G. S., Pfeiffer, L. M., & Hemenway, D. R. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.4.3599 · Cited by 56
Mahad, D., Lawry, J., Howell, S. J., & Woodroofe, M. N. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms899oa · Cited by 48
Okada, T., Sugie, I., & Aisaka, K. (1993) · PubMed · Cited by 46
Noble, P. W. (2003) · PubMed · Cited by 44
Self-citationMing, J., Xingbing, W., Baojun, H., Xiongwin, W., Li, Z., Ping, X., Xu, Y., Anting, L., Chunsong, H., Feili, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1556 · Cited by 39
Campbell, J. D., Stinson, M. J., Simons, F. E. R., & HayGlass, K. T. (2002) · International Immunology · doi:10.1093/intimm/dxf098 · Cited by 22
Klemm, A., Tschernig, T., Krug, N., & Pabst, R. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00657.x · Cited by 16
Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4
Cited by
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Self-citationIntegrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
Groom, J. R., & Luster, A. D. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.017 · Cited by 988
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Metadata
- Authors
- Jiang, D., Liang, J., Hodge, J., Lu, B., Zhu, Z., Yu, S., Fan, J., Gao, Y., Yin, Z., Homer, R., Gerard, C., & Noble, P. W.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-07-15
- Volume
- 114
- Issue
- 2
- Pages
- 291-299
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2120446140
- Cited by
- 303
- References
- 51
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.